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Abstract
Background Ischemic colitis is commonly thought to
occur most often in the left hemicolon close to the splenic
flexure owing to insufficient blood supply near Griffith’s
point. This study investigates the colorectal localization
pattern, the risk factors, and the long-term outcome of
histologically proven ischemic colitis.
Methods Between 1996 and 2004, a total of 49 patients
with a median age of 69 years (range 26–94 years) with
colonoscopically assessed and histologically proven
ischemic colitis were identified on behalf of the pathology
database. Long-term results of 43 patients were evaluated
retrospectively after a median interval of 79 months (range
6–163 months).
Results In 27 patients (55%) more than one location was
affected. We found 98 affected locations in 49 patients.
The distribution of ischemic colitis in our group shows no
significantly preferred location. In an exploratory analysis,
the cecum, ascending colon, and right flexure were affected
significantly more often if intake of a nonsteroidal antiin-
flammatory drug (NSAID) is documented. There was no
association between the location of ischemic colitis and a
history of smoking, peripheral artery occlusive disease,
coronary heart disease, diabetes, or malignant tumor.
Conclusions Ischemic colitis seems not to have a pre-
disposing site of occurrence in the colorectum, especially
Griffith’s point which was not afflicted significantly more
often than other sites. Frequently, ischemic colitis afflicts
more than one colonic location. In patients being treated
with NSAIDs, ischemic colitis was observed significantly
more often in the right hemicolon. Recurrence of ischemic
colitis seems to be rare.
Introduction
Ischemic colitis (IC) is the most prevalent form of gas-
trointestinal ischemia and accounts for 1 in 2000 hospital
admissions [1]. It seems to be the second or third most
frequent cause of hematochezia [2, 3], and its clinical
picture manifests mostly as self-limiting ischemia involv-
ing the mucosa and submucosa and rarely as acute ful-
minant ischemia, which may progress to necrosis and death
[4]. The incidence of IC is most likely underestimated
because the mild form often is of transient nature and
misdiagnosed when patients suffer from other diseases
such as inflammatory bowel disease or infectious colitis
[5–7]. The incidence in the literature according to searches
of bibliographic databases in general populations ranged
from 4.5 to 44 cases per 100,000 person–years [8].
Ischemia of the colon was first described after ligation of
the inferior mesenteric artery during aortic surgery or colon
resection [9, 10]. IC is a noninfectious inflammation of the
bowel caused by intestinal blood flow that is inadequate to
serve the metabolic demands of the colon in a specific
region [1]. The etiology of IC is multifactorial [7, 11, 12].
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Small-vessel diseases such as atherosclerosis, vasculitis,
and amyloidosis can cause IC, as can major cardiovascular
surgery and systemic hypoperfusion due to all kinds of
situations involving shock [1]. A number of drugs are
known to cause IC as a result of their vasoconstrictive
effect, including digoxin, diuretics, estrogen, and nonste-
roidal antiinflammatory drugs (NSAIDs). Additionally, IC
can be associated with systemic diseases (e.g., systemic
lupus erythematosus, Wegener granulomatosis, amyloido-
sis) [13–23].
There are only a few reports with a large number of
patients suffering from IC [6, 24]. It is widely thought that IC
predominantly occurs from the left side of the transverse
colon to the descending colon. This colonic region includes
Griffith’s point, the point of critical blood supply between
the vascular areas of the superior mesenteric artery (SMA)
and the inferior mesenteric artery (IMA). Analyses of arte-
riographic studies show that vascular anastomosis at Grif-
fith’s point is present in 48 to 100% of individuals [25–27].
Overall, the left part of the colon seems to be affected by
IC in [75% of cases [7, 28]. The right part of the colon
including the ileocecal area can be affected as well, but the
incidence is reported to be low [28, 29]. The incidence of
IC in the rectum ranges from 4 to 16% [24]. Most studies
are based on a small number of patients, however, and as
our concerns about the correctness of the location dogma
for IC were growing over the years we aimed to analyze the
colorectal location pattern, the risk factors, and the long-
term outcome of histologically proven IC.
Patients and methods
Patients
We performed a retrospective database query at the Insti-
tute of Pathology, Kantonsspital Liestal, in Liestal, Swit-
zerland from 1996 to 2004 for patients with histologically
confirmed IC. This department processes the histological
examination for all county hospitals and most of the gast-
roenterologists in private practice in the district of Basel-
land. The analyzed tissue specimens were obtained either
by endoscopy or surgery, with none by autopsy.
Inclusion criteria were a macroscopically segmental,
circular inflammation of the colon without histological
signs of inflammatory bowel disease (IBD). To differenti-
ate from NSAID-induced colitis, patients with nummular
inflammation, erosions, or ulceration were excluded. The
histologic changes of IC include edema, distorted crypts,
mucosal and submucosal hemorrhage, inflammatory infil-
tration, granulation tissue, intravascular platelet thrombi,
and necrosis [30]. Patients with IBD usually have less crypt
damage and more inflammation [31]. The presence of a
hyalinized, hemorrhagic lamina propria and full-thickness
mucosal necrosis may help differentiate pseudomembra-
nous colonic ischemia from Clostridium difficile-induced
colitis [4, 32].
The query initially identified 58 patients suffering from
IC. Medical records of all 58 patients were analyzed for
clinical, endoscopic, and pathologic data. Secondary
diagnoses, such as peripheral artery occlusive disease
(PAOD), coronary heart disease, diabetes, or hyperlipo-
proteinemia, and data about duration of illness, number of
endoscopies, mode of therapy, body mass index, and
tobacco use were collected from the medical records as
well. NSAID intake was defined as daily intake of at least
one NSAID dose over a time period of more than 2 weeks
immediately before the symptoms occurred.
The location of ischemia was documented based on
endoscopic or surgical findings. We used the following
exclusion criteria: IBD present or in the history, infectious
colonic inflammation, former abdominal surgery, and prior
bowel obstruction. Two patients were excluded because of
prior sigmoid volvulus, five patients tested positive for
C. difficile, and two patients had acute diverticulitis, leav-
ing a final number of 49 patients for further analyses.
In July 2007, follow-up was performed by questionnaire
to obtain details about the long-term results. The median
time of follow-up was 79 months (range 6–163 months). A
complete follow-up was obtained from 43 of the 49 patients
(87.8%). Regarding the remaining patients, two patients died
within 3 months after diagnosis of IC due to heart failure,
and four patients did not provide concrete, reliable data.
Symptoms or colonoscopy were assessed as a secondary
event if the patient was pain-free for at least 90 days fol-
lowing hospital discharge.
Statistical analysis
Categorical data are presented as absolute and relative
frequencies and the continuous data as the median and
range. Groups were tested for differences by Pearson’s v2
test, Fisher’s exact test, or the Mann-Whitney U test, as
appropriate. Exact 95 percent confidence (95% CI) limits
for binomial proportion were computed by the F distribu-
tion method according to Collett. Statistical significance is
defined as P \ 0.05. All analyses were performed by SAS
9.1.3 (SAS Institute, Cary, NC, USA).
The local ethics committee of Basel and Baselland (Ref.
139/10) approved the study.
Results
A total of 36 women and 13 men were included in the study
(73.5 vs. 26.5%, ratio 2.7:1.0). The median age at the time
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of diagnosis was 69 years (range 26–94 years). Female
patients were significantly older: The median age was
71 years (range 27–94 years) for women versus 60 years
for men (range 26–92 years), P = 0.036. Details are
summarized in Fig. 1.
Location of disease
More than one segment was affected in 27 patients (55.1%).
Overall, we found 98 affected locations in 49 patients.
Ischemic pancolitis was diagnosed in two patients (4.1%).
The allocation to the segments was as follows: cecum,
n = 11 (11.2%); ascending colon, n = 15 (15.3%); right
flexure, n = 6 (6.1%); transverse colon, n = 8 (8.2%); left
flexure, n = 11 (11.2%); descending colon, n = 27
(27.5%); sigmoid, n = 14 (14.3%); rectum, n = 6 (6.1%).
No location was affected with a significantly higher
incidence than any other (Fig. 2).
In patients with NSAID intake, the cecum (37.0 vs.
4.6%, P = 0.013), ascending colon (44.4 vs. 13.6%,
P = 0.029), and right flexure (22.2 vs. 0.0%, P = 0.027)
were significantly more affected than in patients with no
documented NSAID intake. The subgroup analysis for
smoking, peripheral artery occlusive disease, coronary
heart disease, diabetes, and malignant tumor revealed no
preferred allocation among the segments. The allocation of
risk factors to the site of IC is shown in Table 1.
Duration of illness and clinical manifestation
Most of the cases (n = 28, 57.1%) were acute events with
admission to the hospital within 24 h after the first symp-
toms. A total of 37 patients (75.5%) were looking for
medical help from a physician within 3 days. Only two
patients had abdominal pain for more than 1 month. Both
patients were of advanced age (85 and 89 years), were
under continuous NSAID intake due to other diseases, and
had no history of coronary heart disease or diabetes. The
most common symptoms were hematochezia (69.4%),
persistent diarrhea (49.0%), abdominal pain (44.9%), and
pseudoobstruction (26.5%). All of the other clinical man-
ifestations were seen in \5%.
The federal pathology department processes both inpa-
tient and outpatient histological specimens. All cases of IC
were, however, detected in inpatients. The distribution of
the duration of illness until hospital admission is illustrated
in Fig. 3.
Endoscopy
Almost all patients had colonoscopy for diagnosis (n = 46;
93.9%), and IC was always detected at the initial
Fig. 1 Ischemic colitis (IC) with regard to age and sex
Fig. 2 Relative frequencies and
95% confidence intervals of
various locations with ischemic
colitis
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colonoscopy. In all, 30 patients (61.2%) had a single
colonoscopy; 12 patients (24.5%) were examined twice, 8
patients for the purpose of control and 4 patients had
recurring symptoms; 3 patients (6.1%) had three colonos-
copies; and one patient underwent four examinations, all of
which were for persistent symptoms. All colonoscopies
were undertaken during the same hospital stay. In three
patients (6.1%), we diagnosed IC on a specimen resected
by a surgeon.
Therapy
Most of the patients were treated conservatively (n = 45;
91.8%) with analgesics. Only four patients required surgery
(8.2%): Three underwent open right hemicolectomy and
one sigmoid resection. One patient died after surgery
because of multiorgan failure. None of the conservatively
treated patients died within 90 days. The comparison of the
mortality rates is not significant (P = 0.08).
Medication and secondary disease
More than half of the patients had a regular NSAID intake
(n = 29, 59.2%), 17 patients (34.7%) had a history of
nicotine abuse (mean 35.8 pack years), and 14 patients
(28.6%) had a positive history of coronary heart disease.
Only three patients had a positive family history of intes-
tinal disease (6.1%).
Blood lipid measurements were recorded in only 16
patients. Among them, 9 (18.4%) patients had
hyperlipoproteinemia.
In all, 29 patients (59.2%) were overweight or with a
higher weight according to the World Health Organization
classification. Diabetes and malignant tumors were rare in
our group, with only 9 (18.4%) and 5 (10.2%) cases,
respectively.
None of the investigated precipitating causes for IC
(smoking, peripheral occlusive arterial disease, coronary
heart disease, diabetes, malignant tumor) were found in
eight of the patients (16.3%). Among the others, 17 patients
(34.7%) had a single cause and 24 (49.0%) had multiple
causes.
Long-term results
After a median observation time of 79 months (range
6–163 months), 36 of 43 patients (84%) with reliable fol-
low-up were completely free of further abdominal symp-
toms after the initial episode; 7 patients (16%) had
recurrent symptoms. The most frequent symptoms were
abdominal pain, diarrhea, and mild hematochezia. Five of
these patients underwent another colonoscopy (one patient
twice), but in only two cases were signs of IC detectable. In
one patient, IC affected the whole left hemicolon, whereas
at the initial diagnosis of IC the disease was located solely
in the sigmoid colon. The time interval was 4 years. In
the other patient, IC was located in the splenic flexure
(Griffith’s point) only, whereas in the first episode IC was
demonstrated in the whole left hemicolon. The time























Smoking 17 4 (23.5%) 5 (29.4%) 1 (5.9%) 1 (5.9%) 3 (17.7%) 7 (41.2%) 6 (35.3%) 0
NSAIDs 27 10 (37.0%) 12 (44.4%) 6 (22.2%) 6 (22.2%) 5 (18.5%) 13 (51.8%) 9 (33.3%) 4 (14.8%)
PAOD 7 0 2 (28.6%) 1 (14.3%) 1 (14.3%) 2 (28.6%) 3 (42.9%) 2 (28.6%) 0
CHD 14 1 (7.1%) 2 (14.3%) 1 (7.1%) 2 (14.3%) 3 (21.4%) 7 (50.0%) 6 (42.9%) 1 (7.1%)
Diabetes 9 2 (22.2%) 5 (55.5%) 2 (22.2%) 2 (22.2%) 1 (11.1%) 3 (33.3%) 3 (33.3%) 2 (22.2%)
Malignancy 5 1 (20.0%) 2 (40.0%) 1 (20.0%) 1 (20.0%) 0 2 (40.0%) 2 (40.0%) 1 (20.0%)
NSAIDs nonsteroidal antiinflammatory drugs, PAOD peripheral artery occlusive disease, CHD coronary heart disease
Fig. 3 Duration of symptoms of IC in 49 patients prior to hospital
admission
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interval was 1 year. The results of the other three colo-
noscopies were one normal finding, one case of bacterial
colitis, and one case of normal findings apart from
hemorrhoids.
Discussion
Ischemic colitis is the most common form of intestinal
ischemia. It occurs as the result of inadequate intestinal
blood flow, which can result in a spectrum of injuries, from
transient self-limited ischemia to transmural infarction.
Our study included 49 patients with histologically pro-
ven IC. The clinical manifestation of IC was observed
more often in female than in male patients, as has also been
described by Higgins et al. [8]. IC occurs at a significantly
younger age in men than in women. The most frequent
location was the descending colon followed by the
ascending colon. In the literature, IC is mainly reported in
the area from the left side of the transverse colon to
the descending colon [7, 28, 33], which corresponds to the
region of overlapping marginal blood supply due to the
anastomosis between the superior and inferior mesenteric
arteries [34], known as Griffith’s point [26].
We did not observe a predisposition of this location for
IC. In contrast, the allocation of IC to the various segments
of colon is almost equally distributed between the left and
right hemicolon. In 55% (27/49) of the patients, two or
more segments of the colon were afflicted by IC. Even in
the rectum, which has a very good blood supply, IC was
present in six patients (12.5%)—as many as in the right
flexure. Therefore, the authors assume that the patho-
physiology of IC is caused by microembolism or vaso-
constriction of the vasae rectae, which can affect the whole
colorectum with no predominant location. Additionally, the
finding of equal affection of the whole colorectum was also
reported in recent studies. Brandt et al. [35] reported an
affection of the left colon in only 32.6% of 313 patients.
NSAID intake was not analyzed. Zou et al. found left
hemicolon involvement in 80% of 85 patients, but only
14% affected the splenic flexure. The risk factors were
reported but not analyzed for the various segments of the
colon, and NSAID intake was not studied [36]. Acosta
et al. studied 23,446 autopsies in which 53 cases of fatal IC
were identified. They found splenic flexure involvement in
57%, whereas the descending colon was affected in 77%.
This of course differs from our study in that only fatal cases
of IC were considered [37]. Madoff et al. [38] also sug-
gested that the watershed zone is not especially vulnerable
and may even be considered ischemia-resistant based on
the dual circulation in this region. With our data we
showed only equal involvement of all segments of the
colon.
In patients with NSAID intake, the locations of the
right hemicolon were significantly more affected by IC.
This is an interesting finding, particularly with regard to
the fact that patients with signs of NSAID-induced colitis
were excluded from this study. It may be related to the
fact that drugs, which have not been reabsorbed com-
pletely in the small bowel, develop higher local drug
concentrations in the right hemicolon than in the left
hemicolon. In addition to the local toxic effects, which
results in local inflammation, erosions, or ulceration, we
assume that NSAIDs induce local vasoconstriction and
promote IC.
None of the other evaluated risk factors showed a cor-
relation with any colonic site in our study. Studies with a
larger number of patients are necessary in future to give
more information on this topic.
All cases of IC in our study were detected in inpatients,
although the pathology department also processes outpa-
tient specimens. It seems that the clinical manifestations of
IC warrant immediate admission and colonoscopy, which
can by provided only in a hospital. Of course, this finding
depends mainly on the particular public health system.
To analyze the recurrence rate, we prospectively eval-
uated the long-term follow-up. Seven patients (16.3%) had
recurrent episodes of abdominal pain, diarrhea, or hema-
tochezia; and five of these patients underwent re-colonos-
copy. In only two patients (4.6%) were control
colonoscopy and biopsy able to demonstrate the persis-
tence or recurrence of IC. In our study, IC was most often a
transient, self-limiting disease that rarely required surgical
intervention.
Conclusions
Our results indicated that every segment of the colon can
be affected by IC. The area from the left part of the
transverse colon to the descending colon (region of Grif-
fith’s point) did not show a significant higher incidence of
IC than the right hemicolon. In more than half of the
patients, IC had affected two or more segments of the
colon. The right hemicolon was significantly more often
affected than the left hemicolon in patients with NSAID
intake. In most cases, IC is a mild, self-limiting disease that
rarely requires surgical therapy. The recurrence rate of IC
seems to be low. Brandt et al. [35] reported a significantly
higher mortality rate for patients who required surgery. In
our study, one patient died after surgery, whereas none died
after conservative treatment, but the difference was not
significant.
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